Stocks at New 52-Week Highs — Valuation View · Biological Products, (No Diagnostic Substances)
6 stocks match the Stocks at New 52-Week Highs screen. Stocks that have just made a fresh 52-week high — breakout stocks with strong momentum. Valuation columns. Filtered to Biological Products, (No Diagnostic Substances). Updated
Filters2
1–6 of 6
| BIIB | Biogen | $33.1B | 24.16 | 3.34 | 1.78 | 9.80 | — | 224.49 | +0.78% | 32K |
| EXEL | Exelixis, Inc. | $14.7B | 17.03 | 6.02 | 7.95 | 52.06 | — | 59.13 | +1.00% | 116K |
| HALO | Halozyme Therapeutics, Inc. | $12.6B | 30.39 | 7.55 | 87.56 | 77.04 | — | 110.73 | +1.01% | 90K |
| REPL | Replimune Group, Inc. | $1.4B | -4.85 | — | 13.63 | 7.77 | — | 15.28 | -4.32% | 50K |
| ATTO | Attovia Therapeutics, Inc. | $1.2B | — | — | — | 35.22 | — | 25.33 | +3.56% | 23K |
| ARGX | Argenx Se | — | — | — | — | — | — | 1053.32 | -0.21% | 8K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.